Regencell Bioscience Holdings Limited Stock
Equities
RGC
KYG7487R1002
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.35 USD | -18.69% | -32.45% | -58.57% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 300M |
---|---|---|---|---|---|
Net income 2022 | -7M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 15.65M | Net cash position 2023 | 11.1M | EV / Sales 2023 | - |
P/E ratio 2022 |
-59.5
x | P/E ratio 2023 |
-51.1
x | Employees | 12 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.24% |
1 day | -18.69% | ||
1 week | -32.45% | ||
Current month | -3.33% | ||
1 month | +11.54% | ||
3 months | -46.63% | ||
6 months | -72.22% | ||
Current year | -58.57% |
Managers | Title | Age | Since |
---|---|---|---|
Wai Hong Chung
COO | Chief Operating Officer | 46 | - |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-09-30 |
Yat-Pui Au
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wing Yan Lo
BRD | Director/Board Member | 63 | 21-12-12 |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-09-30 |
- | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 4.35 | -18.69% | 4 260 |
24-04-25 | 5.35 | +4.90% | 1,147 |
24-04-24 | 5.1 | -10.53% | 2,609 |
24-04-23 | 5.7 | -11.49% | 27,364 |
24-04-22 | 6.44 | +16.04% | 3,132 |
Delayed Quote Nasdaq, April 29, 2024 at 11:37 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-58.57% | 69.62M | |
+2.58% | 42.75B | |
+47.70% | 41.61B | |
+12.07% | 41.34B | |
-8.83% | 26.59B | |
+7.82% | 25.49B | |
-22.52% | 18.12B | |
+31.13% | 12.24B | |
-1.40% | 11.76B | |
+9.00% | 11B |
- Stock Market
- Equities
- RGC Stock